This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Isabelle O. Arndt, MD, PhD; Leo Dorozynsky, MD; George E. Woody, MD; A. Thomas McLellan, PhD; Charles P. O'Brien, MD, PhD

Arch Gen Psychiatry. 1992;49(11):888-893.

Abstract
• We performed a double-blind, placebo-controlled, randomized 12-week trial of desipramine hydrochloride treatment of cocaine dependence among methadonemaintained patients. Fifty-nine patients completed the 12-week medication trial (36 received desipramine and 23 received placebo), and 94% were recontacted 1, 3, and 6 months after treatment. There were significantly more dropouts in the desipramine than in the placebo group. Baseline to 12-week comparisons of Addiction Severity Index interview data indicated that both groups showed improvements. At 12 weeks, the desipramine group showed significantly better psychiatric status than the placebo group but did not differ from the placebo group on any of 21 other outcome measures, including cocaine use. During the 12-week medication phase and at the 1-month follow-up evaluation, urine toxicology screenings showed no significant difference between groups, but the placebo group had significantly less cocaine use at both the 3- and 6-month follow-up points. We conclude that desipramine has few benefits with regard to control of cocaine use in this population.

Author Affiliations
From the Center for Studies of Addiction at the Philadelphia (Pa) Veterans Administration Medical Center and the University of Pennsylvania, Philadelphia.

Footnotes
Accepted for publication October 29, 1991.

Reprint requests to Building 7, Philadelphia VA Medical Center, University Avenue, Philadelphia, PA 19104 (Dr Arndt).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Why are programmes for offenders with personality disorder not informed by the relevant scientific findings?
Duggan
Phil Trans R Soc B 2008;363:2599-2612.
ABSTRACT | FULL TEXT  

References
APPI Online CME 2007;2007:2-2.
FULL TEXT  

Six-Month Trial of Bupropion With Contingency Management for Cocaine Dependence in a Methadone-Maintained Population
Poling et al.
Arch Gen Psychiatry 2006;63:219-228.
ABSTRACT | FULL TEXT  

Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
Lingford-Hughes et al.
J Psychopharmacol 2004;18:293-335.
 

From the Cover: Treating cocaine addiction with viruses
Carrera et al.
Proc. Natl. Acad. Sci. USA 2004;101:10416-10421.
ABSTRACT | FULL TEXT  

Cocaine-primed craving and its relationship to depressive symptomatology in individuals with cocaine dependence
Elman et al.
J Psychopharmacol 2002;16:163-167.
ABSTRACT  

A Reevaluation of the Exclusion Criteria Used in Antidepressant Efficacy Trials
Posternak et al.
Am. J. Psychiatry 2002;159:191-200.
ABSTRACT | FULL TEXT  

Desipramine in Opioid-Dependent Cocaine Abusers Maintained on Buprenorphine vs Methadone
Oliveto et al.
Arch Gen Psychiatry 1999;56:812-820.
ABSTRACT | FULL TEXT  

Alcohol & Drug Abuse: Practical Guidelines for the Treatment of Substance Abusers With Adult Attention-Deficit Hyperactivity Disorder
Levin et al.
Psychiatr. Serv. 1999;50:1001-1003.
FULL TEXT  

Old Psychotherapies for Cocaine Dependence Revisited
Carroll
Arch Gen Psychiatry 1999;56:505-506.
FULL TEXT  

Imipramine Treatment of Opiate-Dependent Patients With Depressive Disorders: A Placebo-Controlled Trial
Nunes et al.
Arch Gen Psychiatry 1998;55:153-160.
ABSTRACT | FULL TEXT  

Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner et al.
Arch Gen Psychiatry 1997;54:71-80.
ABSTRACT  

One-Year Follow-up of Psychotherapy and Pharmacotherapy for Cocaine Dependence: Delayed Emergence of Psychotherapy Effects
Carroll et al.
Arch Gen Psychiatry 1994;51:989-997.
ABSTRACT  

Noradrenergic Dysregulation During Discontinuation of Cocaine Use in Addicts
McDougle et al.
Arch Gen Psychiatry 1994;51:713-719.
ABSTRACT  

Addiction Medicine
Franklin
JAMA 1993;270:184-185.
ABSTRACT